Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAuburn University
About this trial
The goal of this clinical trial is to learn if a new intervention (Promoting Resilience to Improve Disordered Eating; PRIDE) can decrease internalized stigma and increase the ability to cope effectively with stressors in sexual minority populations diagnosed with eating disorders. The main question it aims to answer is:
Will an eating disorders treatment focused on decreasing internalized stigma and increasing sexual minority stress coping self efficacy in sexual minority populations? Participants Will
* Complete a telephone screen with study staff to determine preliminary eligibility for the study * Undergo a behavioral eligibility screening that includes structured clinical interviewing in order to determine proper diagnosis of an eating disorder along with ensuring absence of non-eating disorder diagnoses * Complete self-report measures to determine study eligibility * Attend up to 14 weekly therapy sessions as part of the PRIDE intervention, where participants will work with qualified clinicians to address eating pathology and disordered body image along with developing effective strategies for coping with sexual minority stressors * Complete surveys upon completion of the intervention 3 and 6 months post follow-up
Eligibility criteria
This trial accepts healthy volunteersQualifiers
age 18 to 65 years
identify as lesbian, gay, bisexual, other non-heterosexual identities
meet criteria for a Diagnostic and Statistical Manual - 5 (DSM-5) eating disorder (i.e., anorexia nervosa, bulimia nervosa, binge eating disorder, other specified feeding or eating disorder)
reports current (past 12 months) experience with discrimination due to sexual orientation;
Disqualifiers
inability to speak/read English
active suicidal plans or intent
other major untreated psychiatric diagnoses (e.g., untreated bipolar disorder, untreated psychosis)
body mass index below 17.0, a standard clinical cutoff used to denote moderate-severe underweight that may be indicated for a higher level of medical care than standard outpatient treatment
Trial design
Design model
Single group
Treatments tested in this trial
Promoting Resilience to Improve Disordered Eating
BehavioralSee description under "Arms"
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: PsychotherapyExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Internalized Homophobia Scale (IHP)
Assesses internalized stigma (9 items, 5-point scale, higher scores indicate greater internalized stigma).
Time frame
Change from Baseline through 3- and 6-month follow-up2
Sexual Orientation Implicit Association Test
Assesses internalized stigma via computerized behavioral task involving categorizing positive/negative words with sexual minority and heterosexual people.
Time frame
Change from Baseline through 3- and 6-month follow-up3
Coping Self Efficacy Scale (CSES)
Assesses sexual minority(SM)-stress coping self efficacy, as adapted for address SM stress in prior research (13 items, 11-point scale, higher scores indicate greater SM-stress coping self-efficacy).
Time frame
Change from Baseline through 3- and 6-month follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Auburn University
Lead sponsor
San Diego State University
Collaborator
Source ClinicalTrials.gov